These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 25753604)
1. The Effects of Parenteral Amino Acid Therapy on Protein Carbamylation in Maintenance Hemodialysis Patients. Kalim S; Ortiz G; Trottier CA; Deferio JJ; Karumanchi SA; Thadhani RI; Berg AH J Ren Nutr; 2015 Jul; 25(4):388-92. PubMed ID: 25753604 [TBL] [Abstract][Full Text] [Related]
2. Longitudinal Changes in Protein Carbamylation and Mortality Risk after Initiation of Hemodialysis. Kalim S; Trottier CA; Wenger JB; Wibecan J; Ahmed R; Ankers E; Karumanchi SA; Thadhani R; Berg AH Clin J Am Soc Nephrol; 2016 Oct; 11(10):1809-1816. PubMed ID: 27445162 [TBL] [Abstract][Full Text] [Related]
3. Protein Carbamylation in Peritoneal Dialysis and the Effect of Low Glucose Plus Amino Acid Solutions. Trottier C; Perl J; Freeman M; Thadhani R; Berg A; Kalim S Perit Dial Int; 2018; 38(2):149-152. PubMed ID: 29563277 [TBL] [Abstract][Full Text] [Related]
4. Carbamylation of serum albumin and erythropoietin resistance in end stage kidney disease. Kalim S; Tamez H; Wenger J; Ankers E; Trottier CA; Deferio JJ; Berg AH; Karumanchi SA; Thadhani RI Clin J Am Soc Nephrol; 2013 Nov; 8(11):1927-34. PubMed ID: 23970130 [TBL] [Abstract][Full Text] [Related]
5. Reduction of carbamylated albumin by extended hemodialysis. Perl J; Kalim S; Wald R; Goldstein MB; Yan AT; Noori N; Kiaii M; Wenger J; Chan C; Thadhani RI; Karumanchi SA; Berg AH Hemodial Int; 2016 Oct; 20(4):510-521. PubMed ID: 27329430 [TBL] [Abstract][Full Text] [Related]
6. Protein Carbamylation and the Risk of ESKD in Patients with CKD. Kalim S; Zhao S; Tang M; Rhee EP; Allegretti AS; Nigwekar S; Karumanchi SA; Lash JP; Berg AH J Am Soc Nephrol; 2023 May; 34(5):876-885. PubMed ID: 36757153 [TBL] [Abstract][Full Text] [Related]
7. Comparative CKD risk prediction using homocitrulline and carbamylated albumin: two circulating markers of protein carbamylation. Awwad A; Rhee EP; Grams M; Choles HR; Sondheimer J; He J; Chen J; Hsu CY; Vasan RS; Kimmel PL; Wulczyn K; Berg A; Lash J; Tang M; Kalim S; BMC Nephrol; 2024 May; 25(1):185. PubMed ID: 38816682 [TBL] [Abstract][Full Text] [Related]
8. Protein carbamylation is associated with heart failure and mortality in diabetic patients with end-stage renal disease. Drechsler C; Kalim S; Wenger JB; Suntharalingam P; Hod T; Thadhani RI; Karumanchi SA; Wanner C; Berg AH Kidney Int; 2015 Jun; 87(6):1201-8. PubMed ID: 25671766 [TBL] [Abstract][Full Text] [Related]
9. Carbamylation of serum albumin as a risk factor for mortality in patients with kidney failure. Berg AH; Drechsler C; Wenger J; Buccafusca R; Hod T; Kalim S; Ramma W; Parikh SM; Steen H; Friedman DJ; Danziger J; Wanner C; Thadhani R; Karumanchi SA Sci Transl Med; 2013 Mar; 5(175):175ra29. PubMed ID: 23467560 [TBL] [Abstract][Full Text] [Related]
10. Intradialytic parenteral nutrition in maintenance hemodialysis patients suffering from protein-energy wasting. Results of a multicenter, open, prospective, randomized trial. Marsen TA; Beer J; Mann H; Clin Nutr; 2017 Feb; 36(1):107-117. PubMed ID: 26708726 [TBL] [Abstract][Full Text] [Related]
11. Carbamylated hemoglobin as a therapeutic marker in hemodialysis. Hasuike Y; Nakanishi T; Maeda K; Tanaka T; Inoue T; Takamitsu Y Nephron; 2002 Jun; 91(2):228-34. PubMed ID: 12053058 [TBL] [Abstract][Full Text] [Related]
12. Effect of intradialytic intravenous administration of omega-3 fatty acids on nutritional status and inflammatory response in hemodialysis patients: a pilot study. Szklarek-Kubicka M; Fijałkowska-Morawska J; Zaremba-Drobnik D; Uciński A; Czekalski S; Nowicki M J Ren Nutr; 2009 Nov; 19(6):487-93. PubMed ID: 19616450 [TBL] [Abstract][Full Text] [Related]
13. The association of intradialytic parenteral nutrition administration with survival in hemodialysis patients. Chertow GM; Ling J; Lew NL; Lazarus JM; Lowrie EG Am J Kidney Dis; 1994 Dec; 24(6):912-20. PubMed ID: 7985668 [TBL] [Abstract][Full Text] [Related]
14. Successful treatment of hypoalbuminemic hemodialysis patients with a modified regimen of oral essential amino acids. Bronich L; Te T; Shetye K; Stewart T; Eustace JA J Ren Nutr; 2001 Oct; 11(4):194-201. PubMed ID: 11679999 [TBL] [Abstract][Full Text] [Related]
15. Effect of Sevelamer and Nicotinamide on Albumin Carbamylation in Patients with End-Stage Kidney Disease. Lenglet A; Rahali MA; Sauvage FL; Liabeuf S; Choukroun G; Essig M; El Balkhi S; Massy ZA Drugs R D; 2021 Jun; 21(2):231-238. PubMed ID: 34101139 [TBL] [Abstract][Full Text] [Related]
17. Effect of intradialytic parenteral nutrition in patients with malnutrition-inflammation complex syndrome on body weight, inflammation, serum lipids and adipocytokines: results from a pilot study. Joannidis M; Rauchenzauner M; Leiner B; Rosenkranz A; Ebenbichler CF; Laimer M; Tatarczyk T; Meusburger E; Mayer G Eur J Clin Nutr; 2008 Jun; 62(6):789-95. PubMed ID: 17522619 [TBL] [Abstract][Full Text] [Related]
18. Effects of Oral Nutritional Supplements on Mortality, Missed Dialysis Treatments, and Nutritional Markers in Hemodialysis Patients. Benner D; Brunelli SM; Brosch B; Wheeler J; Nissenson AR J Ren Nutr; 2018 May; 28(3):191-196. PubMed ID: 29221626 [TBL] [Abstract][Full Text] [Related]
19. Correction formula for carbamylated haemoglobin in diabetic uraemic patients. Hammouda AM; Mady GE Ann Clin Biochem; 2001 Mar; 38(Pt 2):115-9. PubMed ID: 11269750 [TBL] [Abstract][Full Text] [Related]
20. How to Prevent Renal Cachexia? A Clinical Randomized Pilot Study Testing Oral Supplemental Nutrition in Hemodialysis Patients With and Without Human Immunodeficiency Virus Infection. Zilles M; Betz C; Jung O; Gauer S; Hammerstingl R; Wächtershäuser A; Vogl TJ; Geiger H; Asbe-Vollkopf A; Pliquett RU J Ren Nutr; 2018 Jan; 28(1):37-44. PubMed ID: 29146139 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]